CITR Files 8th S-1/A Amid Zero Revenue, Persistent Losses

TL;DR

**Avoid CITR; eight S-1/A amendments and zero revenue signal a highly speculative and likely value-destructive investment.**

AI Summary

General Enterprise Ventures, Inc. (CITR) filed an S-1/A on August 11, 2025, marking its eighth amendment to the registration statement 333-282611, indicating a prolonged path to public offering. The company, operating in Chemicals & Allied Products (SIC 2800), reported a net loss of $1,000 for the three months ended March 31, 2025, compared to a net loss of $1,000 for the same period in 2024, showing no improvement in profitability. Revenue remained at $0 for both periods, highlighting a lack of operational sales. The S-1/A confirms the company's intention for a delayed or continuous offering under Rule 415, suggesting flexibility in its capital raise strategy. Key risks include its status as a 'smaller reporting company' and 'emerging growth company,' which allows for reduced disclosure requirements but may deter some investors. The strategic outlook remains unclear given the absence of revenue and persistent losses, with the filing primarily focused on regulatory compliance for its proposed public sale.

Why It Matters

This S-1/A filing is critical for investors as it reveals General Enterprise Ventures, Inc. (CITR) has yet to generate any revenue, reporting $0 for the three months ended March 31, 2025, and a net loss of $1,000. This prolonged pre-revenue state, coupled with eight amendments to its S-1, signals significant operational challenges and a high-risk investment profile. For employees, the lack of revenue raises concerns about long-term stability and growth prospects. In the competitive Chemicals & Allied Products sector, CITR's inability to launch commercial operations puts it far behind established players, making market penetration extremely difficult. The broader market should view this as a cautionary tale regarding early-stage companies with extended registration processes and no demonstrable business activity.

Risk Assessment

Risk Level: high — The risk level is high due to General Enterprise Ventures, Inc.'s reported $0 in revenue for the three months ended March 31, 2025, and a net loss of $1,000 for the same period. This indicates a complete lack of operational business activity and profitability. Furthermore, the filing is the eighth amendment to its S-1 registration statement (333-282611), suggesting significant delays and potential issues in its path to a public offering.

Analyst Insight

Investors should exercise extreme caution and likely avoid General Enterprise Ventures, Inc. (CITR) given its zero revenue and persistent losses. This S-1/A primarily serves as a regulatory update, not an indicator of business progress, and potential investors should wait for clear evidence of revenue generation and a viable business model before considering any investment.

Financial Highlights

revenue

$0

net Income

-$1,000

revenue Growth

0.0%

Key Numbers

• $0 — Revenue (For the three months ended March 31, 2025, indicating no sales activity.)
• $1,000 — Net Loss (For the three months ended March 31, 2025, showing continued unprofitability.)
• 8 — Amendment Number (This is the eighth amendment to the S-1 registration statement, suggesting a prolonged and complex registration process.)
• 333-282611 — Registration No. (The SEC file number for the S-1 registration statement.)
• 2800 — SIC Code (Primary Standard Industrial Classification Code for Chemicals & Allied Products.)

Key Players & Entities

• General Enterprise Ventures, Inc. (company) — Registrant filing S-1/A
• Theodore Ralston (person) — Chief Executive Officer of General Enterprise Ventures, Inc.
• Anthony F. Newton (person) — Counsel for General Enterprise Ventures, Inc.
• David E. Danovitch, Esq. (person) — Counsel for General Enterprise Ventures, Inc. from Sullivan & Worcester LLP
• Aaron M. Schleicher, Esq. (person) — Counsel for General Enterprise Ventures, Inc. from Sullivan & Worcester LLP
• SEC (regulator) — United States Securities and Exchange Commission
• Sullivan & Worcester LLP (company) — Law firm providing counsel to General Enterprise Ventures, Inc.
• Law Office of Anthony F. Newton (company) — Law firm providing counsel to General Enterprise Ventures, Inc.

FAQ

Risk Factors

• Prolonged Registration Process [medium — regulatory]: The company has filed its eighth amendment (Amendment No. 8) to the S-1 registration statement (333-282611) on August 11, 2025. This extended timeline suggests potential complexities or issues encountered during the registration process, which could indicate underlying challenges or a lack of preparedness for a public offering.
• Absence of Revenue and Persistent Losses [high — financial]: For the three months ended March 31, 2025, General Enterprise Ventures, Inc. reported $0 in revenue, mirroring the $0 revenue from the same period in 2024. Concurrently, the company incurred a net loss of $1,000 for the first quarter of 2025, unchanged from the prior year's first quarter. This indicates a complete lack of sales activity and no improvement in profitability, raising significant concerns about the company's business model and viability.
• Smaller Reporting Company Status [medium — regulatory]: General Enterprise Ventures, Inc. qualifies as a 'smaller reporting company' and an 'emerging growth company.' While this status allows for reduced disclosure requirements, it may also signal a higher risk profile to potential investors who prefer more comprehensive financial and operational transparency.
• Unclear Strategic Outlook [high — operational]: The absence of revenue and the continued net loss of $1,000 for the three months ended March 31, 2025, make the company's strategic direction and future operational plans unclear. The S-1/A filing appears primarily focused on meeting regulatory requirements for a public sale rather than detailing a path to generating sales or achieving profitability.

Industry Context

General Enterprise Ventures, Inc. operates within the Chemicals & Allied Products sector (SIC 2800). This industry is typically characterized by significant research and development, complex manufacturing processes, and stringent regulatory oversight. Competition can be intense, with established players and specialized niche companies. Trends often involve innovation in materials science, sustainability, and compliance with environmental regulations.

Regulatory Implications

The company's status as a 'smaller reporting company' and 'emerging growth company' allows for reduced disclosure requirements, which could be a double-edged sword. While easing the compliance burden, it may also lead to increased investor scrutiny and skepticism due to a lack of comprehensive information.

What Investors Should Do

1. Scrutinize the business plan and revenue generation strategy.
2. Evaluate the implications of reduced disclosure requirements.
3. Monitor future filings for any signs of operational progress.

Key Dates

• 2025-08-11: Filing of S-1/A Amendment No. 8 — Indicates a prolonged and potentially complex registration process for the company's initial public offering.
• 2025-03-31: End of First Quarter 2025 — Period for which the latest financial results ($0 revenue, $1,000 net loss) are reported, showing no operational progress.
• 2024-03-31: End of First Quarter 2024 — Prior year period for comparison, showing identical revenue ($0) and net loss ($1,000), highlighting a lack of year-over-year improvement.

Glossary

S-1/A

An amendment to a registration statement filed with the SEC on Form S-1. It is used by companies planning to go public to provide updated or corrected information before the IPO becomes effective. (This is the primary filing document for General Enterprise Ventures, Inc.'s proposed public offering, indicating its status and the ongoing regulatory process.)

Rule 415

A regulation that permits companies to register securities for an offering that may be made on a 'delayed or continuous' basis. This allows for flexibility in timing and pricing of the offering. (The company is utilizing Rule 415, suggesting it wants flexibility in how and when it raises capital through its public offering.)

Smaller Reporting Company

A company that meets certain criteria regarding public float and revenue, allowing it to file scaled-down disclosure documents with the SEC. (General Enterprise Ventures, Inc. is classified as such, which may impact investor perception due to reduced transparency requirements.)

Emerging Growth Company

A company that has total annual gross revenues of less than $1.235 billion during its most recently completed fiscal year. This status provides certain exemptions from regulatory requirements. (This classification, along with 'smaller reporting company,' allows for reduced disclosure, potentially affecting investor confidence.)

SIC Code

Standard Industrial Classification code, a four-digit number used to classify industries and businesses in the United States. (The company's SIC code is 2800 (Chemicals & Allied Products), providing context for its industry sector.)

Year-Over-Year Comparison

The S-1/A filing on August 11, 2025, shows no change in the company's financial performance compared to the prior year's comparable period. Revenue remains at $0 for the three months ended March 31, 2025, and the net loss is unchanged at $1,000. The prolonged registration process, indicated by the eighth amendment, is a key development, suggesting ongoing challenges in bringing the company to market. No new significant risks appear to have been introduced, but the fundamental issues of zero revenue and persistent losses remain the primary concerns.

Filing Documents

• gevi_s1a.htm (S-1/A) — 84KB
• gevi_ex41.htm (EX-4.1) — 100KB
• 0001640334-25-001400.txt ( ) — 307KB
• gevi-20250331.xsd (EX-101.SCH) — 5KB
• gevi-20250331_lab.xml (EX-101.LAB) — 11KB
• gevi-20250331_cal.xml (EX-101.CAL) — 1KB
• gevi-20250331_pre.xml (EX-101.PRE) — 7KB
• gevi-20250331_def.xml (EX-101.DEF) — 2KB
• gevi_s1a_htm.xml (XML) — 3KB

EXHIBITS

Item 16. EXHIBITS (a) Documents filed as exhibits hereto: Incorporated by Reference Exhibit Number Exhibit Description Form Exhibit Filing Date 1.1 Form of Underwriting Agreement S-1 1.1 8/08/2025 3.1 Articles of Domestication/Articles of Incorporation 10-K 3.1 4/15/2024 3.2 Amendment to Articles of Incorporation 10-K 3.2 3/31/2025 3.3 Bylaws 10-K 3.3 4/15/2024 3.4 Second Amended and Restated Designations and Preferences of Series A Preferred Stock 10-K 3.4 3/31/2025 3.5 Amended and Restated Designations and Preferences of Series C Convertible Preferred Stock 10-K 3.5 3/31/2025 3.6 Form of Amended and Restated Articles of Incorporation S-1 3.6 8/4/2025 3.7 Form of Amended and Restated Bylaws S-1 3.7 8/4/2025 4.1 Form of Representative's Warrants 4.2 Form of Warrant Agreement issued with Convertible Note, dated July 2024 S-1 4.2 10/11/2024 4.3 Form of Convertible Note, dated July 2024 S-1 4.3 10/11/2024 4.4 Warrant Agreement dated February 28, 2025, by and between the Company and BoltRock Holdings, LLC S-1 4.4 5/27/2025 4.5 Form of Warrant Agreement dated March 7, 2025, by and between the Company and its Placement Agents S-1 4.5 5/27/2025 4.6 Form of Warrant Agreement dated March 7, 2025, by and between the Company, and Univest Securities, LLC or Bradley Richmond S-1 4.6 5/27/2025 4.7 Warrant Agreement (W-34) between the Company and Bradley Richmond S-1 4.7 8/4/2025 4.8 Warrant Agreement (W-35) between the Company and Bradley Richmond S-1 4.8 8/4/2025 4.9 Warrant Agreement (W-36) between the Company and Bradley Richmond S-1 4.9 8/4/2025 4.10 Warrant Agreement (W-37) between the Company and Bradley Richmond S-1 4.10 8/4/2025 4.11 Warrant Agreement (W-38) between the Company and Univest Securities, LLC S-1 4.11 8/4/2025 5.1 Opinion of Law Office of Anthony F. Newton, regarding the validity of securities being registered S-1

Undertakings

Item 17. Undertakings The undersigned registrant hereby undertakes: (a) The undersigned registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the "Securities Act"); (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission (the "Commission") pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement. (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; Provided, however, that Paragraphs (a)(1)(i), (ii), and (iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that are incorporated by reference in the registration statement. (2) That, for the purpose of

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Cheyenne, State of Wyoming on August 11, 2025. GENERAL ENTERPRISE VENTURES, INC. By: /s/ Theodore Ralston Theodore Ralston President and Chief Executive Officer Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. Signature Title Date /s/ Theodore Ralston Director, Chairman, President, and Chief Executive Officer August 11, 2025 Theodore Ralston (Principal Executive Officer) /s/ Nanuk Warman Secretary and Chief Executive Officer August 11, 2025 Nanuk Warman (Principal Financial Officer and Principal Accounting Officer) /s/ Jeffery Pomerantz Director August 11, 2025 /s/ John Costa Director August 11, 2025 II-5

View Full Filing

View this S-1/A filing on SEC EDGAR